# Assessement of Potential Interest of [68Ga]Ga-PentixaFor PET/CT in Metastatic Triple Negative Breast Cancer Patients

> **NCT06962163** · NA · RECRUITING · sponsor: **Institut Cancerologie de l'Ouest** · enrollment: 12 (estimated)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** [68Ga]Ga-PentixaFor PET/CT

## Key facts

- **NCT ID:** NCT06962163
- **Lead sponsor:** Institut Cancerologie de l'Ouest
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-05
- **Primary completion:** 2027-06
- **Final completion:** 2030-06
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06962163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06962163, "Assessement of Potential Interest of [68Ga]Ga-PentixaFor PET/CT in Metastatic Triple Negative Breast Cancer Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06962163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*